Carl V. Hamby

1.3k total citations
39 papers, 1.0k citations indexed

About

Carl V. Hamby is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Carl V. Hamby has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Carl V. Hamby's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cell Adhesion Molecules Research (5 papers). Carl V. Hamby is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cell Adhesion Molecules Research (5 papers). Carl V. Hamby collaborates with scholars based in United States, Italy and China. Carl V. Hamby's co-authors include Bijan Safai, Jennifer Leininger, David M. Weinstein, Tomomichi Ono, M Temponi, Soldano Ferrone, Joseph M. Backer, Toshiro Kageshita, Daniel Patschan and Zhongtao Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Carl V. Hamby

36 papers receiving 1.0k citations

Peers

Countries citing papers authored by Carl V. Hamby

Since Specialization

Citations

This map shows the geographic impact of Carl V. Hamby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl V. Hamby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl V. Hamby more than expected).

Fields of papers citing papers by Carl V. Hamby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl V. Hamby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl V. Hamby. The network helps show where Carl V. Hamby may publish in the future.

Co-authorship network of co-authors of Carl V. Hamby

This figure shows the co-authorship network connecting the top 25 collaborators of Carl V. Hamby. A scholar is included among the top collaborators of Carl V. Hamby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl V. Hamby. Carl V. Hamby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mobilization of Endogenous CD34+/CD133+ Endothelial Progenitor Cells by Enhanced External Counter Pulsation for Treatment of Refractory Angina 2024 ·International Journal of Molecular Sciences ·(unknown), Carol A. Eisenberg, (unknown), (unknown), (unknown), Carl V. Hamby	0
2	Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients 2018 ·Pediatric Blood & Cancer ·Olga Militano, M. Fevzi Özkaynak, (unknown), (unknown), Carl V. Hamby, Mitchell S. Cairo	4
3	Cord Blood-Derived Stem Cells Suppress Fibrosis and May Prevent Malignant Progression in Recessive Dystrophic Epidermolysis Bullosa 2018 ·Stem Cells ·Yanling Liao, Larisa Ivanova, Hongwen Zhu, (unknown), Carl V. Hamby, (unknown), (unknown), Angela M. Christiano, John A. McGrath, Mitchell S. Cairo	15
4	The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia 2018 ·Bone Marrow Transplantation ·Jessica Hochberg, (unknown), Mark B. Geyer, Nan Chen, (unknown), Lauren Harrison, Olga Militano, M. Fevzi Özkaynak, Alexandra Cheerva, Julie‐An Talano, Theodore B. Moore, Alfred P. Gillio, Mark C. Walters, Lee Ann Baxter‐Lowe, Carl V. Hamby, Mitchell S. Cairo	4
5	Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by ALT-803, an IL-15 superagonist 2016 ·Experimental Hematology ·Yaya Chu, (unknown), Carl V. Hamby, (unknown), Brian Hang, Janet Ayello, (unknown), Hongwen Zhu, Hing C. Wong, Dean A. Lee, Mitchell S. Cairo	1
6	IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas 2015 ·PLoS ONE ·Xin Huang, Haein Park, J.T. Greene, (unknown), (unknown), (unknown), Catherine M. Albert, Fred Moy, Deepali Sachdev, Douglas Yee, Christoph Rader, Carl V. Hamby, David M. Loeb, Mitchell S. Cairo, Xianzheng Zhou	88
7	Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculature 2013 ·Journal of Biomedical Optics ·Saeid Zanganeh, Yan Xu, Carl V. Hamby, Marina V. Backer, Joseph M. Backer, Quing Zhu	19
8	Targeted Systemic Radiotherapy with scVEGF/¹⁷⁷Lu Leads to Sustained Disruption of the Tumor Vasculature and Intratumoral Apoptosis 2011 ·Journal of Nuclear Medicine ·Francis G. Blankenberg, Zoia Levashova, (unknown), Carl V. Hamby, Marina V. Backer, Joseph M. Backer	14
9	Molecular Imaging of Changes in the Prevalence of Vascular Endothelial Growth Factor Receptor in Sunitinib-Treated Murine Mammary Tumors 2010 ·Journal of Nuclear Medicine ·Zoia Levashova, Marina V. Backer, Carl V. Hamby, John Pizzonia, Joseph M. Backer, Francis G. Blankenberg	21
10	Inhibition of Vascular Endothelial Growth Factor Receptor Signaling in Angiogenic Tumor Vasculature 2009 ·Advances in genetics ·Marina V. Backer, Carl V. Hamby, Joseph M. Backer	13
11	Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 2005 ·Biochemical and Biophysical Research Communications ·Tze‐chen Hsieh, Zhirong Wang, Carl V. Hamby, Joseph Wu	63
12	Loss of beta-catenin expression associated with disease progression in malignant melanoma 2001 ·British Journal of Dermatology ·Toshiro Kageshita, Carl V. Hamby, T Ishihara, Kazuhiko Matsumoto, Toshiaki Saida, Tomomichi Ono	106
13	Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells 2000 ·International Journal of Cancer ·Carl V. Hamby, Rakesh Abbi, (unknown), (unknown), (unknown), Charmaine E. Mendola, V. Sidorov, Joseph M. Backer	19
14	Increased β2‐microglobulin‐free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens 2000 ·Tissue Antigens ·Francesco Puppo, Sabrina Brenci, Paola Contini, Donatella Bignardi, Carl V. Hamby, Gilberto Filaci, Massimo Ghio, M. Scudeletti, A. Picciotto, Francesco Indiveri, Soldano Ferrone	4
15	Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2–23 1998 ·International Journal of Cancer ·Carl V. Hamby, Marco Chinol, Christopher J. Palestro, Ciro Manzo, Soldano Ferrone	2
16	Decreased 3 α-Hydroxysteroid Dehydrogenase Activity in Peripheral Blood Lymphocytes from Patients with Primary Open Angle Glaucoma 1996 ·Experimental Eye Research ·B I Weinstein, Radha Iyer, (unknown), Carl V. Hamby, Ira Schwartz, Fred Moy, (unknown), (unknown)	16
17	Differential Expression and Mutation of nme Genes in Autologous Cultured Human Melanoma Cells with Different Metastatic Potentials 1995 ·Biochemical and Biophysical Research Communications ·Carl V. Hamby, Charmaine E. Mendola, (unknown), Grace A. Stafford, Joseph M. Backer	21
18	Alterations in angiotensin II receptor mediated signal transduction shortly after coronary artery constriction in the rat 1994 ·Cardiovascular Research ·Hui‐Fu Huang, P. Li, Carl V. Hamby, Krzysztof Reiss, Leonard G. Meggs, P. Anversa	9
19	Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues 1993 ·Journal of Immunological Methods ·M Temponi, (unknown), Carl V. Hamby, (unknown), Charles C. Marboe, (unknown)	54
20	Human hepatic 3α-hydroxysteroid dehydrogenase: Possible identity with human hepatic chlordecone reductase 1992 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Carl V. Hamby, Victor A. Fried, Ira Schwartz, B I Weinstein, A. Louis Southren	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact